Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr;197(2):951-8.
doi: 10.1016/j.atherosclerosis.2007.09.001. Epub 2007 Oct 30.

Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging

Affiliations

Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging

Justin M S Lee et al. Atherosclerosis. 2008 Apr.

Abstract

Effective LDL-cholesterol (LDL-C) reduction improves vascular function and can bring about regression of atherosclerosis. Alterations in endothelial function can occur rapidly, but changes in atherosclerosis are generally considered to occur more slowly. Vascular magnetic resonance imaging (MRI) is a powerful technique for accurate non-invasive assessment of central and peripheral arteries at multiple anatomical sites. We report the changes in atherosclerosis burden and arterial function in response to open label statin treatment, in 24 statin-naïve newly diagnosed stable coronary artery disease patients. Patients underwent MRI before, and 3 and 12 months after commencing treatment. Mean LDL-C fell by 37% to 70.8 mg/dL (P<0.01). The plaque index (normalised vessel wall area) showed reductions in the aorta (2.3%, P<0.05) and carotid (3.1%, P<0.05) arteries at 3 months. Early reductions in atherosclerosis of aorta and carotid observed at 3 months were significantly correlated with later change at 12 months (R(2)=0.50, P<0.001; R(2)=0.22, P<0.05, respectively). Improvements in aortic distensibility and brachial endothelial function that were apparent after 3 months treatment were sustained at the 12-month time point.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Plaque index in the aorta is reduced in response to statin treatment. Significant reductions were observed between baseline and 3 months and between 3 and 12 months (* indicates P < 0.05 vs. baseline, † indicates P < 0.05 vs. 3 months). (b) Proton density weighted image of descending thoracic aorta showing a well-defined, eccentric, mildly lobulated plaque in the descending thoracic aorta (arrow). (c) Change in plaque index (ΔPI) at 3 months was significantly correlated to the change measured at 12 months.
Fig. 2
Fig. 2
(a) Plaque index in the carotid arteries was reduced in response to statin treatment. Significant reductions were observed between baseline and 3 months but not between 3 and 12 months (* indicates P < 0.05 vs. baseline). (b) T2 weighted magnetic resonance image of the common carotid arteries (arrows) demonstrating bilateral non-obstructive common carotid plaques. (c) Change in plaque index (ΔPI) at 3 months was significantly correlated to the change measured at 12 months.

References

    1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9. - PubMed
    1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7–22. - PubMed
    1. Taylor A.J., Kent S.M., Flaherty P.J. ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106:2055–2060. - PubMed
    1. Smilde T.J., van Wissen S., Awollersheim H. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. Lancet. 2001;357:577. - PubMed
    1. Nissen S.E., Nicholls S.J., Sipahi I. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556–1565. - PubMed

Publication types

Substances